EW

Edwards Lifesciences Corp.

Price

$83.42

return (12m)

10.95%

p/e

48.96

p/bv

4.59

DIVIDEND YIELD

0.00%

EW price

Edwards Lifesciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment EW

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-3.66%

3 months

-9.62%

1 year

10.95%

2 years

22.21%

5 years

-23.11%

10 years

111.80%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals EW

Valuation

P/E

48.96

Sector 1.05

Industry 3.46

P/BV

4.59

Sector 1.86

Industry 2.13

P/Revenue (PSR)

7.55

Sector 1.55

Industry 1.72

EV/EBITDA

81.01

Sector -46.43

Industry 1.72

EV/EBIT

87.66

Sector -49.92

Industry -4.29

P/EBITDA

29.78

Sector -31.75

Industry -53.68

P/EBIT

33.09

Sector -43.66

Industry -50.97

P/Total Assets

3.55

Sector 0.85

Industry 0.96

P/Net Current Assets

13.38

Sector -25.85

Industry -11.19

P/Working Capital

9.26

Sector -3.91

Industry 2.92

EPS

1.74

Sector -0.69

Industry -0.60

BVPS

18.61

Sector 4.52

Industry 4.74

Efficiency

Gross Margin

77.84%

Sector 49.51%

Industry 50.68%

EBITDA Margin

32.29%

Sector -280.81%

Industry -57.47%

EBIT Margin

29.84%

Sector -163.94%

Industry -56.25%

Operating Margin

22.25%

Sector -19.83%

Industry -25.80%

Net Profit Margins

15.43%

Sector -24.02%

Industry -29.17%

Asset Turnover

0.13

Sector 0.13

Industry 0.15

Profitability

ROE

9.37%

Sector -23.79%

Industry -22.30%

ROA

7.25%

Sector -24.20%

Industry -24.15%

ROIC

11.28%

Sector -584.46%

Industry -96.49%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

4.52

Sector 1.91

Industry 1.98

Net Debt / EBITDA

-6.50

Sector -23.21

Industry -2.21

Net Debt / EBIT

-7.03

Sector -17.93

Industry -1.50

Net Debt / Equity

-0.34

Sector -0.68

Industry -0.29

Gross Debt / Equity

0.06

Sector -0.72

Industry -0.82

Equity/Assets

0.77

Sector 0.46

Industry 0.47

Liabilities/Assets

0.23

Sector 0.50

Industry 0.52

Growth

5Y Revenue CAGR

4.47%

Sector -

Industry -

5Y Earnings CAGR

-7.74%

Sector -

Industry -

Fundamentals EW

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Edwards Lifesciences ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$83.42

Fair Value

$26.99

Upside

-67.64%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
EW Edwards Lifesciences Corp.	$83.42	10.14%	0.00%	48.96	4.59	9.37%	15.43%
ABT Abbott Laboratories	$99.62	-23.07%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$87.72	-6.71%	3.30%	21.10	2.17	10.29%	13.93%
BSX Boston Scientific Corp.	$42.17	-56.44%	0.00%	17.31	2.55	14.73%	17.49%
TMDX TransMedics Group Inc.	$79.00	-31.41%	0.00%	17.68	5.18	29.28%	22.69%
RMD ResMed Inc.	$229.57	-17.84%	1.12%	20.92	4.84	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$518.98	-17.61%	0.00%	36.04	25.47	70.67%	25.03%
COHR Coherent Inc.	$307.35	163.43%	0.00%	81.57	5.84	7.16%	11.31%
SYK Stryker Corp.	$278.73	-24.73%	1.27%	28.21	4.38	15.55%	14.43%
PHG Koninklijke Philips NV	$24.13	-11.22%	4.25%	17.60	1.72	9.80%	6.30%
INMD InMode Ltd.	$14.17	-5.88%	0.00%	10.69	1.32	12.32%	20.69%
BDX Becton Dickinson and Company	$182.79	-3.40%	2.39%	51.40	1.98	3.85%	6.29%
DXCM DexCom Inc.	$83.78	23.60%	0.00%	32.65	12.45	38.14%	20.12%
ALGN Align Technology Inc.	$141.86	6.59%	0.00%	25.13	2.46	9.77%	9.99%
SNN Smith & Nephew PLC	$27.05	-22.09%	2.96%	19.66	4.27	21.74%	9.20%
IRMD iRadimed Corporation	$86.93	14.39%	1.49%	47.27	10.71	22.66%	26.70%
ZBH Zimmer Biomet Holdings Inc.	$88.94	-8.38%	1.10%	20.85	1.33	6.39%	9.48%
HSIC Henry Schein Inc.	$83.86	29.55%	0.00%	23.66	2.50	10.56%	2.96%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

EW - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Edwards Lifesciences

Edwards Lifesciences Corp.

Average Investor10 user rating

4.0 (15 people)

United States

27 years

Founded: 1999

2000

Time since IPO - 26 years

14.900

Employees

Edwards Lifesciences Corp. (United States) is listed on the NYSE and has a market capitalization of $49.20 billion, with shareholders equity totaling $10.72 billion.

The company employs approximately 14.900 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Edwards Lifesciences Corp. reported $6.51 billion in revenue, generating net income of $1.00 billion.

Key financial metrics include a P/E ratio of 48.96, a price-to-book (P/B) ratio of 4.59, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker EW.

Market cap

$49.20 billion

Net worth

$10.72 billion

$10,724,900,000.00

Assets

$13.87 billion

$13,867,100,000.00

Total Shares Outstanding

576.40 million

576,400,000

Average Daily Trading Volume

$3.53 million

$3,534,954.00

Sector

Health

Industry

Medical Supplies and Equipment

revenue by Business Segment Edwards Lifesciences

Revenue by Region Edwards Lifesciences

EW revenue and profits

Financial Results EW

DRAG THE FRAME TO SEE MORE DATA

EW cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$87.23 16,40% (12M)

P/E

22.49

3.09%

ROE

6.12%

P/BV

1.38

CI - Cigna

$282.51 --3,94% (12M)

P/E

10.33

2.31%

ROE

16.04%

P/BV

1.66

CNC - Centene

$65.98 84,51% (12M)

P/E

-6.05

0.00%

ROE

-22.53%

P/BV

1.36

HUM - Humana

$436.13 58,23% (12M)

P/E

35.89

0.93%

ROE

6.63%

P/BV

2.38

SNY - Sanofi

$40.11 --13,32% (12M)

P/E

3.72

4.45%

ROE

18.43%

P/BV

0.69

JNJ - Johnson & Johnson

$260.17 39,50% (12M)

P/E

29.27

2.06%

ROE

24.76%

P/BV

7.25

LLY - Eli Lilly

$1,172.61 41,58% (12M)

P/E

38.06

0.59%

ROE

78.84%

P/BV

30.01

HCA - HCA Healthcare

$447.24 8,25% (12M)

P/E

13.82

0.71%

ROE

-213.15%

P/BV

-29.45